MK Anwer, M Mohammad, E Ezzeldin… - International journal …, 2019 - Taylor & Francis
Background Apremilast (APM) is a novel, orally administered small molecule drug approved
for treatment of psoriasis or psoriatic arthritis. Due to its low solubility and permeability, it is …